Dr. Lal PathLabs LimitedNSE: LALPATHLAB

Press Release Jan 29 2021

· Issued by Dr. Lal PathLabs Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The company reported a significant increase in revenue, with a notable contribution from Covid-related services. Normalized EBITDA and profit after tax also showed substantial growth compared to the same quarter last year. Additionally, the Board approved an interim dividend for shareholders.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 29, 2021, titled "Press Release for Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2020".

Dr. Lal PathLabs Limited on 6ix

Earlier from Dr. Lal PathLabs

Later from Dr. Lal PathLabs

All Dr. Lal PathLabs news releases